Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Jovitta Jacob
University of Texas at Houston - Department of Leukemia
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
73
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Results of Salvage Therapy with Mini-Hyper-CVD and Inotuzumab Ozogamicin with or Without Blinatumomab in Pre-B Acute Lymphoblastic Leukemia
Number of pages: 45
Posted: 06 Dec 2022
Hagop Kantarjian
,
Nitin Jain
,
Koji Sasaki
,
Elias Jabbour
,
Fadi G. Haddad
,
Sanam Loghavi
,
Rashmi Kanagal-Shamanna
,
Jeffrey Jorgensen
,
Issa Khouri
,
Partow Kebriaei
,
Yesid Alvarado
,
Tapan M. Kadia
,
Shilpa Paul
,
Guillermo Garcia-Manero
,
Bouthaina Dabaja
,
Musa Yilmaz
, Jovitta Jacob,
Rebecca Garris
,
Susan O'Brien
,
Farhad Ravandi
and
Elias Jabbour
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Hematopathology, University of Texas at Houston - Department of Hematopathology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Pharmacy, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of California, Irvine - Chao Family Comprehensive Cancer Center, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads
73
(860,052)
View PDF
Download
Abstract:
Philadelphia-negative ALL, inotuzumab, blinatumomab, chemo-immunotherapy, salvage, outcome
Feedback